Full Text View
Tabular View
No Study Results Posted
Related Studies
J-Pouch Coloanal Anastomosis Compared With Side-to-End Coloanal Anastomosis After Radiation Therapy and Surgery to Remove the Rectum in Treating Patients With Rectal Adenocarcinoma
This study is ongoing, but not recruiting participants.
First Received: October 3, 2003   Last Updated: May 9, 2009   History of Changes
Sponsored by: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Information provided by: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT00070005
  Purpose

RATIONALE: A coloanal anastomosis may be effective in restoring bowel function after radiation therapy and surgery to remove the rectum. It is not yet known whether a J-pouch coloanal anastomosis is more effective than a side-to-end coloanal anastomosis in restoring bowel function in patients with rectal adenocarcinoma who have undergone radiation therapy and surgery to remove the rectum.

PURPOSE: This randomized phase III trial is studying how well J-pouch coloanal anastomosis works compared to side-to-end coloanal anastomosis in treating patients with rectal adenocarcinoma who have undergone radiation therapy and surgery to remove the rectum.


Condition Intervention Phase
Colorectal Cancer
Perioperative/Postoperative Complications
Procedure: conventional surgery
Procedure: management of therapy complications
Phase III

Study Type: Interventional
Study Design: Supportive Care, Randomized, Active Control
Official Title: A Phase III Randomised Study Of J-Pouch Coloanal Anastomosis Versus Side-To-End Coloanal Anastomosis After Preoperative Radiotherapy And Total Mesorectal Excision In Patients With Mid And Distal Rectal Cancer

Resource links provided by NLM:


Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:
  • Functional outcome as measured by a validated questionnaire

Secondary Outcome Measures:
  • Quality life as measured by a validated questionnaire
  • Anorectal function as assessed by anorectal manometry and barostat measurements

Estimated Enrollment: 100
Study Start Date: June 2002
Detailed Description:

OBJECTIVES:

Primary

  • Compare functional outcome in patients with mid- or distal rectal adenocarcinoma when treated with J-pouch coloanal anastomosis vs side-to-end coloanal anastomosis after preoperative radiotherapy and total mesorectal excision.

Secondary

  • Compare the quality of life of patients treated with these procedures.
  • Compare anorectal function in patients treated with these procedures.

OUTLINE: This is a randomized, multicenter study. Patients are stratified according to participating center and gender. Patients are randomized to 1 of 2 treatment arms.

  • Arm I: Patients undergo total mesorectal excision followed by a J-pouch coloanal anastomosis.
  • Arm II: Patients undergo total mesorectal excision followed by a side-to-end coloanal anastomosis.

In both arms, patients receive a temporary ileostomy. The ileostomy is closed after 1 week provided recovery is uneventful and no radiological signs of anastomotic leakage are detected. If early closure is not possible, the ileostomy is closed after 6-8 weeks.

Functional outcome, quality of life, and anorectal function are assessed before surgery and at 4 and 12 months after surgery.

PROJECTED ACCRUAL: A minimum of 100 patients (50 per treatment arm) will be accrued for this study.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

DISEASE CHARACTERISTICS:

  • Histologically confirmed adenocarcinoma of the rectum

    • T2 or T3 disease
  • Disease located in the mid- or distal rectum
  • No evidence of metastatic disease
  • No preexisting grade III or IV incontinence
  • Completed preoperative radiotherapy (5 x 5 Gy) before study entry

PATIENT CHARACTERISTICS:

Age

  • Over 18

Performance status

  • WHO 0-2

Life expectancy

  • Not specified

Hematopoietic

  • Not specified

Hepatic

  • Not specified

Renal

  • Not specified

Other

  • Working knowledge of the Dutch language

PRIOR CONCURRENT THERAPY:

Biologic therapy

  • Not specified

Chemotherapy

  • No prior chemotherapy

Endocrine therapy

  • Not specified

Radiotherapy

  • See Disease Characteristics
  • No prior radiotherapy to the pelvis

Surgery

  • No prior colon resection
  • No prior anorectal surgery
  • No concurrent abdominoperineal resection
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00070005

Locations
Netherlands
Academisch Medisch Centrum at University of Amsterdam
Amsterdam, Netherlands, 1105 AZ
Albert Schweitzerziekenhuis - Locatie Amstelwijck
Dordrecht NM, Netherlands, NL-3317
Gelre Ziekenhuizen - Lokatie Lukas
Apeldoorn, Netherlands, 7300 DS
Isala Klinieken - locatie Weezenlanden
Zwolle, Netherlands, 8000 GK
St. Lucas - Andreas Ziekenhuis
Amsterdam, Netherlands, 1091 AE
Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Amsterdam, Netherlands, 1066 CX
Onze Lieve Vrouwe Gasthuis
Amsterdam, Netherlands, 1091 HA
Reinier de Graaf Group - Delft
Delft, Netherlands, 2625 AD
Isala Klinieken - locatie Sophia
Zwolle, Netherlands, 8000 GK
Sponsors and Collaborators
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Investigators
Study Chair: Roel Bakx, MD Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
  More Information

Additional Information:
No publications provided

Study ID Numbers: CDR0000328269, CKTO-2002-02-POCASTER, EU-20247
Study First Received: October 3, 2003
Last Updated: May 9, 2009
ClinicalTrials.gov Identifier: NCT00070005     History of Changes
Health Authority: United States: Federal Government

Keywords provided by National Cancer Institute (NCI):
perioperative/postoperative complications
stage I rectal cancer
stage II rectal cancer
stage III rectal cancer
adenocarcinoma of the rectum

Study placed in the following topic categories:
Digestive System Neoplasms
Rectal Neoplasms
Gastrointestinal Diseases
Colonic Diseases
Rectal Neoplasm
Intestinal Diseases
Rectal Diseases
Intestinal Neoplasms
Carcinoma
Rectal Cancer
Digestive System Diseases
Postoperative Complications
Gastrointestinal Neoplasms
Adenocarcinoma
Colorectal Neoplasms
Neoplasms, Glandular and Epithelial

Additional relevant MeSH terms:
Neoplasms by Histologic Type
Digestive System Neoplasms
Gastrointestinal Diseases
Rectal Neoplasms
Colonic Diseases
Intestinal Diseases
Rectal Diseases
Intestinal Neoplasms
Carcinoma
Neoplasms
Pathologic Processes
Neoplasms by Site
Digestive System Diseases
Postoperative Complications
Gastrointestinal Neoplasms
Adenocarcinoma
Colorectal Neoplasms
Neoplasms, Glandular and Epithelial

ClinicalTrials.gov processed this record on September 03, 2009